Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
In the absence of other risk factors, do you treat the regional lymph nodes in triple negative breast cancer?
Or for that matter, offer PMRT on the basis of a patient having triple negative disease?
Answer from: Radiation Oncologist at Community Practice
At present I don't, but once Canadian and EORTC studies are published with full details available, it may change practice patterns.
Sign in or Register to read more
415
Related Questions
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
What are your top takeaways in Radiation Oncology from SABCS 2024?
How do the results of INSEMA and SOUND impact the decision of omitting SLND in young women with breast cancer and offering adjuvant RT to patients who would otherwise be candidates for omission?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
Is it appropriate to use bolus with hypofractionated PMRT?
What are your top takeaways in Breast Cancer from ASTRO 2024?
Would you recommend PMRT for multifocal IDC with extensive LVI and 1 SLN with ITCs?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?